Exploring the relationship between coagulation profiles and histopathological diagnosis of breast lumps: a case control study from Vindhya region, India
DOI:
https://doi.org/10.18203/2349-2902.isj20250142Keywords:
aPTT, Breast lump, D-Dimer, PTAbstract
Background: Breast cancer is the most common cancer among women in India. The country is on the verge of a potential breast cancer epidemic in the coming decade, driven by lifestyle changes such as delayed marriage and childbirth, influenced by Western trends. Hypercoagulable state is one of the adverse complication seen in cases of breast cancer, according to recent study. Therefore, the purpose of this study was to evaluate the coagulation anomalies in breast cancer patients.
Methods: The study was a prospective, case control study carried out with patients presenting with complaints of lump in the breast which were confirmed to be malignant by histopathological examination.
Results: Values of PT and aPTT were found to be comparable in patients with breast cancer when compared with controls. D-Dimers were found to be significantly elevated in patients with breast cancer when compared with controls. D-Dimers were also elevated in cases with high histological grade of cancer and lymphovascular invasion.
Conclusions: Elevated levels of plasma D-dimer may offer some insight for the diagnosis breast lump.
Metrics
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. DOI: https://doi.org/10.3322/caac.21660
Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers and Current Treatment Strategies-An Updated Review. Cancers (Basel). 2021;13(17):4287. DOI: https://doi.org/10.3390/cancers13174287
Han X, Zha H, Yang F, Guo B, Zhu B. Tumor-derived tissue factor aberrantly activates complement and facilitates lung tumor progression via recruitment of myeloid-derived suppressor cells. International journal of molecular sciences. 2017;18(1):22. DOI: https://doi.org/10.3390/ijms18010022
Leppert U, Eisenreich A. The role of tissue factor isoforms in cancer biology. International journal of cancer. 2015;137(3):497503. DOI: https://doi.org/10.1002/ijc.28959
Caine GJ, Stonelake PS, Rea D, Lip GY. Coagulopathic complications in breast cancer. Cancer. 2003;15:1578–86. DOI: https://doi.org/10.1002/cncr.11702
Chew HK, Wun T, Harvey DJ, Zhou H, White RH. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol. 2007;15:70–6. DOI: https://doi.org/10.1200/JCO.2006.07.4393
Saki N, Javan M, Shokouhian M, Bagheri M, Moghimian-boroujeni B. A review of the interaction between the coagulation system and cancer. Iranian Journal of Blood and Cancer. 2023;15(1):71-9. DOI: https://doi.org/10.58209/ijbc.15.1.71
Lal I, Dittus K, Holmes CE. Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res. 2013;15(4):207. DOI: https://doi.org/10.1186/bcr3425
Sringeri R R, Chandra P S. Role of plasma D-dimer levels in breast cancer patients and its correlation with clinical and histopathological stage. Indian Journal of Surgical Oncology. 2018;9:307-11. DOI: https://doi.org/10.1007/s13193-017-0682-x
Tinholt M, Sandset PM, Iversen N. Polymorphisms of the coagulation system and risk of cancer. Throm Res. 2016;140:49-54. DOI: https://doi.org/10.1016/S0049-3848(16)30098-6
Singh AK, Malviya R. Coagulation and inflammation in cancer: Limitations and prospects for treatment. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2022;1877(3):188727. DOI: https://doi.org/10.1016/j.bbcan.2022.188727
Liu L, Zhang X, Yan B, Gu Q, Zhang X, Jiao J, et al. Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients. PloS one. 2014;9(3):90547. DOI: https://doi.org/10.1371/journal.pone.0090547
Lei Z, Guo D. Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer. Blood Coagul Fibrinol. 2021;32(8):572-7. DOI: https://doi.org/10.1097/MBC.0000000000001084
Unsal E, Atalay F, Atikcan S, Yilmaz A. Prognostic significance of haemostatic parameters in patients with lung cancer. Respir Med. 2004;98:93–8. DOI: https://doi.org/10.1016/j.rmed.2003.07.001
Rella C, Coviello M, Frenza ND. Plasma D-dimer measurement as a marker of gynecological tumors: comparison with CA 125. Tumori. 1993;79:347–51. DOI: https://doi.org/10.1177/030089169307900513
Procedure280 AF. of IACTS, February 2018. Indian J Thor Cardiovas Surg. 2018;34(2):181-331. DOI: https://doi.org/10.1007/s12055-018-0649-8
Huang Q, Chen J, Huang Y, Xiong. The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma. Research Square (Research Square). 2023;9:123-8. DOI: https://doi.org/10.21203/rs.3.rs-2497413/v1
Tas F, Kilic L, Duranyildiz D. Coagulation tests show significant differences in patients with breast cancer. Tumor Biol. 2014;35(6):5985–92. DOI: https://doi.org/10.1007/s13277-014-1793-4
Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, Dewhirst M, Greenberg C. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000;18(3):600-9. DOI: https://doi.org/10.1200/JCO.2000.18.3.600
Rajendran G, Aravind D, Venkatesh P, Anandan H. Correlation of coagulation markers with axillary lymph node metastasis in carcinoma breast. Int Surg J. 2018;5:1394-8. DOI: https://doi.org/10.18203/2349-2902.isj20181117
Downloads
Published
How to Cite
Issue
Section
